Ludwig Institute for Cancer Research

This article is not adequately provided with supporting documents (for example individual proofs ). Information without sufficient evidence could be removed soon. Please help Wikipedia by researching the information and including good evidence.

The Ludwig Institute for Cancer Research (LICR) is a global medical research facility that conducts both basic and clinical cancer research .

The LICR was founded in 1971 by the American shipowner and philanthropist Daniel K. Ludwig , who invested a significant part of his billion- dollar fortune in this institute.

With around 900 employees in seven countries, the LICR is the world's largest academic institute dedicated to cancer research. It is represented at the following locations (and research focuses):

• Brussels (Human Cancer Cell Genetics)
• Lausanne (immunology)
• London (cell and molecular biology)
• Melbourne (tumor biology)
• New York (Human Cancer Immunology)
• San Diego (cancer genetics)
• São Paulo (Cancer Biology & Epidemiology)
• Stockholm (molecular and cell biology)
• Uppsala (regulation of cell growth)
• Oxford

Web link

• Homepage

Footnotes

1. ↑ https://www.ludwigcancerresearch.org/about/
2. ↑ About Ludwig Cancer Research. Retrieved July 13, 2020 .